Ethell, Iryna M.
University of California, Riverside
19 papers on CoChatORCID 0000-0002-1324-6611
Most cited papers
- Verified
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., & Ethell, I. M. (2009) · Journal of Medical Genetics
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 465
- Verified
Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research
Protease and Inhibitor MechanismsNeuroscience and Neuropharmacology Research
Cited by 378
- Verified
EphB/syndecan-2 signaling in dendritic spine morphogenesis
Ethell, I. M., Irie, F., Kalo, M. S., Couchman, J. R., Pasquale, E. B., & Yamaguchi, Y. (2001) · Neuron
Axon Guidance and Neuronal SignalingNeuroscience and Neuropharmacology Research
Cited by 309
- Verified
Open-label add-on treatment trial of minocycline in fragile X syndrome.
Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M., & Ethell, D. W. (2010) · BMC Neurology
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 223
- Verified
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Reinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience
Genetics and Neurodevelopmental DisordersProtease and Inhibitor Mechanisms
Cited by 219
- Verified
Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons.
Ethell, I. M., & Yamaguchi, Y. (1999) · The Journal of Cell Biology
Neuroscience and Neuropharmacology ResearchProteoglycans and glycosaminoglycans research
Cited by 209
- Verified
Integrins Control Dendritic Spine Plasticity in Hippocampal Neurons through NMDA Receptor and Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Actin Reorganization
Shi, Y., & Ethell, I. M. (2006) · The Journal of Neuroscience
Neuroscience and Neuropharmacology ResearchCell Adhesion Molecules Research
Cited by 200
- Verified
The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience
Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders
Cited by 170
- Verified
Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice
Wen, T. H., Afroz, S., Reinhard, S. M., Palacios, A. R., Tapia, K., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · Cerebral Cortex
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 165
- Verified
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model
Sidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 155
- Verified
Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
Lovelace, J. W., Ethell, I. M., Binder, D. K., & Razak, K. A. (2018) · Neurobiology of Disease
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 154
- Verified
Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome
Rotschafer, S. E., Trujillo, M. S., Dansie, L. E., Ethell, I. M., & Razak, K. A. (2012) · Brain Research
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 130
- Verified
Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome
Lovelace, J. W., Wen, T. H., Reinhard, S., Hsu, M. S., Sidhu, H., Ethell, I. M., Binder, D. K., & Razak, K. A. (2016) · Neurobiology of Disease
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 115
- Verified
Side Effects of Minocycline Treatment in Patients With Fragile X Syndrome and Exploration of Outcome Measures
Utari, A., Chonchaiya, W., Rivera, S. M., Schneider, A., Hagerman, R. J., Faradz, S. M. H., Ethell, I. M., & Nguyen, D. V. (2010) · American Journal on Intellectual and Developmental Disabilities
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 105
- Verified
Matrix metalloproteinase‐7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation
Bilousova, T. V., Rusakov, D. A., Ethell, D. W., & Ethell, I. M. (2006) · Journal of Neurochemistry
Neuroscience and Neuropharmacology ResearchProtease and Inhibitor Mechanisms
Cited by 98
- Verified
Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
Dansie, L. E., Phommahaxay, K., Okusanya, A. G., Uwadia, J., Huang, M., Rotschafer, S. E., Razak, K. A., Ethell, D. W., & Ethell, I. M. (2013) · Neuroscience
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 95
- Verified
Acute pharmacological inhibition of matrix metalloproteinase‐9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice
Pirbhoy, P. S., Rais, M., Lovelace, J. W., Woodard, W., Razak, K. A., Binder, D. K., & Ethell, I. M. (2020) · Journal of Neurochemistry
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 62
- Verified
Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
Peteri, U., Pitkonen, J., de Toma, I., Nieminen, O., Utami, K. H., Strandin, T. M., Corcoran, P., Roybon, L., Vaheri, A., Ethell, I., et al. (2021) · Glia
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 16
- Verified
An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
Talvio, K., Wagner, V. A., Minkeviciene, R., Kirkwood, J. S., Kulinich, A. O., Umemori, J., Bhatia, A., Hur, M., Käkelä, R., Ethell, I. M., et al. (2023) · Communications Biology
Genetics and Neurodevelopmental DisordersCholesterol and Lipid Metabolism
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free